Management of adverse events related to new cancer immunotherapy (immune checkpoint inhibitors)
- PMID: 28490308
- DOI: 10.5694/mja16.01357
Management of adverse events related to new cancer immunotherapy (immune checkpoint inhibitors)
Comment on
-
Management of adverse events related to new cancer immunotherapy (immune checkpoint inhibitors).Med J Aust. 2016 Nov 7;205(9):418-424. doi: 10.5694/mja16.00586. Med J Aust. 2016. PMID: 27809739 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
